The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by PAR-21-329.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,252,590 in first-year total cost, median $419,984.
Most frequent study sections
- Radiation Therapeutics and Biology Study Section[RTB]3
- Special Emphasis Panel[ZRG1 BDCN-Q (55)]2
- Brain Injury and Neurovascular Pathologies Study Section[BINP]1
- Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]1
- Clinical Neuroplasticity and Neurotransmitters Study Section[CNNT]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA-IRVINE2
- CHILDREN'S HOSP OF PHILADELPHIA1
- DUKE UNIVERSITY1
- SAINT LOUIS UNIVERSITY1
- THOMAS JEFFERSON UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Fingolimod and Ozanimod for the treatment and prevention of chemobrain1R01CA261979-01A1 | FARR, SUSAN ASALVEMINI, DANIELA | SAINT LOUIS UNIVERSITY, MO | $442,415 | ZRG1 |
| 2022 | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy1R37CA267905-01 | GEISLER, STEFANIE | WASHINGTON UNIVERSITY, MO | $419,474 | CNNT |
| 2021 | Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation1R01CA254955-01A1 | MCCORMACK, SHANA ERINMOSTOUFI-MOAB, SOGOL | CHILDREN'S HOSP OF PHILADELPHIA, PA | $771,376 | CHSA |
| 2021 | Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system1R01CA263806-01 | BOTA, DANIELA ANNENELIEGUPTA, KALPNA | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $634,722 | ZRG1 |
| 2021 | Glial immune signaling in radiation-induced brain injury1R01CA251110-01A1 | ACHARYA, MUNJAL M | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $419,984 | RTB |
| 2021 | Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities1R01CA251136-01A1 | HANKS, BRENT ALLEN | DUKE UNIVERSITY, NC | $396,432 | ZRG1 |
| 2021 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence1R01CA255840-01 | CSISZAR, ANNA | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $331,688 | BINP |
| 2021 | Characterization of the cellular mechanisms of radiation induced brain necrosis for clinical intervention1R01CA255596-01A1 | GROSSHANS, DAVID R | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $174,886 | RTB |
| 2020 | Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy1R01CA252484-01 | LU, BO | THOMAS JEFFERSON UNIVERSITY, PA | $661,613 | RTB |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.